Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.
Duchenne muscular Dystrophy (DMD) is an inherited disease caused by mutations in the dystrophin gene that disrupt the open reading frame, while in frame mutations result in Becker muscular dystrophy (BMD). Ullrich congenital muscular dystrophy (UCMD) is due to mutations affecting collagen VI genes....
Main Authors: | Irina T Zaharieva, Mattia Calissano, Mariacristina Scoto, Mark Preston, Sebahattin Cirak, Lucy Feng, James Collins, Ryszard Kole, Michela Guglieri, Volker Straub, Kate Bushby, Alessandra Ferlini, Jennifer E Morgan, Francesco Muntoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3840009?pdf=render |
Similar Items
-
State-of-the-art Advances in Duchenne Muscular Dystrophy
by: Henriette Van Ruiten, et al.
Published: (2017-03-01) -
Mortality cost of Duchenne muscular dystrophy
by: Erik Landfeldt, et al.
Published: (2017-04-01) -
The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy
by: Dominic Scaglioni, et al.
Published: (2021-01-01) -
Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
by: Fernanda Fortunato, et al.
Published: (2021-02-01) -
Duchenne Muscular Dystrophy: From Diagnosis to Therapy
by: Maria Sofia Falzarano, et al.
Published: (2015-10-01)